Personalized and preventive mHealth predicting life-threatening arrhythmias in cardiac patients
- Conditions
- Cardiac arrhythmiasheart rhythm disorder10007521
- Registration Number
- NL-OMON50154
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
- Patients >=18 years old and have undergone ICD or CRT-D implantation for
either primary or secondary prevention less than 5 years prior to enrollment;
- Are participating in a remote monitoring program at AUMC or RIGS;
- Having received appropriate or inappropriate ICD therapy or ventricular
arrhythmias in the last 8 years prior to enrollment.
Unwilling to participate;
Study participants with a life expectancy of less than one year;
Study participants with circumstances that prevent follow-up (emigration,
change of hospital for follow-up);
Study participants who are unable to wear the GENEAactiv wrist-band (e.g.
allergic to the material);
Clinically unstable study participants;
NYHA-class IV;
Study participants unable to complete a questionnaire;
Does not understand the local language (Dutch or Danish);
Serious physical disability (e.g. wheelchair-bound);
A planned ablation for ventricular tachycardia (VT;
Significant movement disorder (i.e. hemiplegia or Parkinsons disease or
similar)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint is the occurrence of inappropriate or appropriate<br /><br>ICD-therapy between baseline and 12-months follow-up. </p><br>
- Secondary Outcome Measures
Name Time Method